Medtronic develops healthcare technology to treat chronic disease. Its medical technology is providing lifelong solutions for people with chronic pain. Medtronic has four main business units: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases that include heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes.

Research Grants 42 show all


$209.6K
2016

$9.2M
2017

$17M
2018

$21.4M
2019

$9.2M
2020

Patents 33,576show all

  • 11,184
    A61N - Electrotherapy
  • 8,507
    A61B - Diagnosis
  • 5,282
    A61M - Devices for introducing media into, or onto, the body
  • 3,272
    A61F - Filters implantable into blood vessels
  • 1,322
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 1,232
    G06F - Electric digital data processing
  • 1,088
    G16H - Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data
  • 853
    A61K - Preparations for medical, dental, or toilet purposes
  • 485
    H01M - Processes or means, e.g. batteries, for the direct conversion of chemical into electrical energy
  • 455
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 802show all

414N/A97Phase 437Phase 344Other

SEC Filings show all


184
8-K

64
10-Q

22
10-K

Contact Information

710 Medtronic Parkway
Minneapolis, MN 55432-5604
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$357,000,00010000+2020-06-15Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2020-06-15$337,000,000Post Ipo EquityBlackstone Life Sciences
2016-08-15$20,000,000Post Ipo EquityTrade Capital Funding